FDA delays approval for life-saving drugs

By ACSH Staff — Sep 30, 2014
In his recent opinion piece published in the New York Post, ACSH friend and former trustee (and former FDA official) Dr. Henry Miller questions the FDA s decision to grant permission for expanded access to

In his recent opinion piece published in the New York Post, ACSH friend and former trustee (and former FDA official) Dr. Henry Miller questions the FDA s decision to grant permission for expanded access to

Researchers claim association between antibiotics and childhood obesity. We say not so fast.

By ACSH Staff — Sep 30, 2014
By the age of two, one in ten children are considered obese. Considering that obesity early in life puts one at greater risk of obesity later in life, childhood obesity is something to pay attention to. Now, a new study

By the age of two, one in ten children are considered obese. Considering that obesity early in life puts one at greater risk of obesity later in life, childhood obesity is something to pay attention to. Now, a new study

Health News Update: September 29, 2014

By ACSH Staff — Sep 29, 2014
The latest in health news: a new cancer drug prolongs life, an FDA-approved device could be key in distinguishing between cognitive impairment and Alzheimer's disease, and why heart attacks may look very different in women

The latest in health news: a new cancer drug prolongs life, an FDA-approved device could be key in distinguishing between cognitive impairment and Alzheimer's disease, and why heart attacks may look very different in women

The use of PET-scan imaging to evaluate cognitive impairment and dementia

By ACSH Staff — Sep 29, 2014
Recently, the FDA has approved new PET tracers as clinical tools to estimate brain amyloid burden in patients being evaluated for cognitive impairment or dementia. And these new tracers - tau-protein tracers - may be

Recently, the FDA has approved new PET tracers as clinical tools to estimate brain amyloid burden in patients being evaluated for cognitive impairment or dementia. And these new tracers - tau-protein tracers - may be

Women s heart attacks may not resemble the typical pattern, and too often kill

By ACSH Staff — Sep 29, 2014
When most people picture heart attacks, they think of sudden, intense chest pain causing the person to grimace in agony, clutching his chest. However, the presenting symptoms of a heart attack can be totally different for women.

When most people picture heart attacks, they think of sudden, intense chest pain causing the person to grimace in agony, clutching his chest. However, the presenting symptoms of a heart attack can be totally different for women.

Clinical trials find that breast cancer drug Perjeta extends survival

By ACSH Staff — Sep 29, 2014
Last year, the advisory committee to the FDA voted to advise approval of a cancer drug, Perjeta, that could be used to treat breast cancer patients before surgery. Now, a new clinical trial sponsored by Swiss drug maker

Last year, the advisory committee to the FDA voted to advise approval of a cancer drug, Perjeta, that could be used to treat breast cancer patients before surgery. Now, a new clinical trial sponsored by Swiss drug maker

Ho Hum. Blum is Glum

By ACSH Staff — Sep 26, 2014
Here she goes again. Deborah Blum couldn t resist bemoaning the state of our environment this time, trace chemicals in water. In her New York Times Sept 25th blog, A Rising Tide of Contaminants, Blum seems to be trying to convince us that we are drinking pure poison. If followed to its logical conclusion, one might wonder why anyone is still alive.

Here she goes again. Deborah Blum couldn t resist bemoaning the state of our environment this time, trace chemicals in water. In her New York Times Sept 25th blog, A Rising Tide of Contaminants, Blum seems to be trying to convince us that we are drinking pure poison. If followed to its logical conclusion, one might wonder why anyone is still alive.

General Mills treads a fine line between activists and science

By ACSH Staff — Sep 26, 2014
Shareholders of food company behemoth General Mills soundly rejected a move to eliminate genetically engineered (GMO) ingredients from the company s product line.

Shareholders of food company behemoth General Mills soundly rejected a move to eliminate genetically engineered (GMO) ingredients from the company s product line.

Half of HIV-infected gay and bisexual men not receiving adequate treatment

By ACSH Staff — Sep 26, 2014
A recent study by the from US Centers for Disease Control and Prevention (CDC) reports that half of gay and bisexual men infected with HIV are not getting the treatment they need to stay healthy.

A recent study by the from US Centers for Disease Control and Prevention (CDC) reports that half of gay and bisexual men infected with HIV are not getting the treatment they need to stay healthy.

Flu shot options for seniors

By ACSH Staff — Sep 25, 2014
Fall is here as of this past Monday, and flu season is not too far away. The CDC recommends flu shots for everyone over 6 months of age, and doctors are especially pushing flu shots for seniors.

Fall is here as of this past Monday, and flu season is not too far away. The CDC recommends flu shots for everyone over 6 months of age, and doctors are especially pushing flu shots for seniors.